Eli Lilly's Mounjaro, a once-weekly injectable medication, has recently launched in India, sparking significant interest and inquiries regarding its use for weight loss. Approved by India's drug regulator, Mounjaro is priced at 4,375 rupees ($50.86) for a 5 milligram vial and 3,500 rupees for a 2.5 mg vial, representing its lowest available doses in the market.

This pricing strategy contrasts sharply with that in the United States, where Mounjaro carries a list price of $1,079.77 per month. However, the actual amount paid by patients in the U.S. typically varies depending on their specific insurance plans and coverage.

The introduction of Mounjaro in India has generated considerable buzz, with many individuals seeking information about its efficacy and suitability for their weight management goals. The drug's availability offers a new option for those struggling with weight loss, although it's crucial for potential users to consult with healthcare professionals to determine if Mounjaro is appropriate for their individual health needs and circumstances.

For comprehensive business news, including updates on Budget 2025, Sensex, and Nifty, as well as personal finance insights and expert opinions, readers are encouraged to visit Moneycontrol or download the Moneycontrol App.

User Consent Notice: Moneycontrol utilizes cookies and other tracking technologies to enhance user experience, analyze website usage, and provide personalized content and advertisements. By accepting the use of cookies, users agree to the updated privacy policy and warrant that they are above 16 years of age. Consent includes the processing of personal data for personalized recommendations, advertisements, and direct marketing communications.